THERALASE TECHNOLOGIES INC. ("TLT") ("TLT.WT")
BULLETIN TYPE: Prospectus-Unit Offering, New Listing-Warrants
BULLETIN DATE: August 22, 2019
TSX Venture Tier 2 Company
Prospectus-Unit Offering
Effective August 20, 2019, the Company's final short form prospectus dated August 19, 2019 qualifying the distribution of 50,000,000 Units of the Company, was filed with and accepted by TSX Venture Exchange (the "Exchange"), and filed with and receipted by the Ontario Securities Commission. Under Multilateral Instrument 11-102 - Passport System the prospectus is deemed to have been filed with and receipted by the securities regulators for each of the British Columbia, Alberta, Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland and Labrador Securities Commissions.
The Exchange has been advised that the closing of the offering occurred on August 22, 2019, for gross proceeds of CDN$17,250,000.
Offering: 50,000,000 Units plus 7,500,000 over-allotment Units
Unit Price: CDN$0.30 per Unit. Each Unit consists of one common share and one common share purchase warrant, with each warrant being exercisable into one common share at CDN$0.35 until expiry, which is 60 months following the closing date.
Underwriter(s): Mackie Research Capital Corporation and Maxim Group LLC, a United States registered broker-dealer, as sub-agent for any sales of the Units in the United States.
Underwriter(s) Commission: An aggregate of CDN$910,384.50 in cash and 2,023,076 compensation options. Each compensation option entitles the holder to acquire one Unit at CDN$0.30 for a period of five years.
Over-Allotment Option: The over-allotment was exercised in full to purchase an additional 7,500,000 Units.
Listing of Warrants:
Effective at the opening, Monday, August 26, 2019, the common share purchase warrants of the Company will commence trading on TSX Venture Exchange. The Company is classified as a 'Medical Device Development' company.
Corporate Jurisdiction: Canada
Capitalization: up to 59,523,076 warrants created and authorized, of which 57,500,000 are issued and outstanding
Transfer Agent: TSX Trust Company
Trading Symbol: TLT.WT
CUSIP Number: 88337V134
These warrants were issued under a warrant indenture dated August 22, 2019 pursuant to the Company's short form prospectus dated August 19, 2019. Each warrant entitles the holder to purchase one common share of the Company at a price of CDN$0.35 per share until expiry, which is 60 months following the closing date.
For further details, please refer to the Company's short form prospectus dated August 19, 2019 and news releases June 26, 2019, August 1, 2019 and August 22, 2019.
______________________________________
|
|
